183 related articles for article (PubMed ID: 21939724)
1. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
Domínguez A; Ciruela P; García-García JJ; Moraga F; de Sevilla MF; Selva L; Coll F; Muñoz-Almagro C; Planes AM; Codina G; Jordán I; Esteva C; Hernández S; Soldevila N; Cardeñosa N; Batalla J; Salleras L
Vaccine; 2011 Nov; 29(48):9020-5. PubMed ID: 21939724
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
Domínguez Á; Ciruela P; Hernández S; García-García JJ; Soldevila N; Izquierdo C; Moraga-Llop F; Díaz A; F de Sevilla M; González-Peris S; Campins M; Uriona S; Martínez-Osorio J; Solé-Ribalta A; Codina G; Esteva C; Planes AM; Muñoz-Almagro C; Salleras L
PLoS One; 2017; 12(8):e0183191. PubMed ID: 28806737
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study.
Barricarte A; Castilla J; Gil-Setas A; Torroba L; Navarro-Alonso JA; Irisarri F; Arriazu M
Clin Infect Dis; 2007 Jun; 44(11):1436-41. PubMed ID: 17479939
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
5. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.
Dominguez A; Salleras L; Fedson DS; Izquierdo C; Ruiz L; Ciruela P; Fenoll A; Casal J
Clin Infect Dis; 2005 May; 40(9):1250-7. PubMed ID: 15825026
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.
Deceuninck G; De Wals P; Boulianne N; De Serres G
Pediatr Infect Dis J; 2010 Jun; 29(6):546-9. PubMed ID: 20125062
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.
Miller E; Andrews NJ; Waight PA; Slack MP; George RC
Vaccine; 2011 Nov; 29(49):9127-31. PubMed ID: 21983361
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.
Ciruela P; Soldevila N; Hernández S; Selva L; de Sevilla MF; García-García JJ; Moraga F; Planes AM; Muñoz-Almagro C; Domínguez A
Vaccine; 2013 Jan; 31(6):960-6. PubMed ID: 23261046
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens.
Mahon BE; Hsu K; Karumuri S; Kaplan SL; Mason EO; Pelton SI; ;
Vaccine; 2006 Mar; 24(14):2514-20. PubMed ID: 16417951
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method.
Rückinger S; van der Linden M; Reinert RR; von Kries R
Vaccine; 2010 Jul; 28(31):5012-6. PubMed ID: 20546832
[TBL] [Abstract][Full Text] [Related]
13. 13-valent pneumococcal conjugate vaccine.
Prescrire Int; 2011 Jan; 20(112):5-7, 9. PubMed ID: 21462782
[TBL] [Abstract][Full Text] [Related]
14. Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.
De Serres G; Pilishvili T; Link-Gelles R; Reingold A; Gershman K; Petit S; Farley MM; Harrison LH; Lynfield R; Bennett NM; Baumbach J; Thomas A; Schaffner W; Beall B; Whitney C; Moore M
Vaccine; 2012 Jun; 30(27):4067-72. PubMed ID: 22525797
[TBL] [Abstract][Full Text] [Related]
15. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(43):1477-81. PubMed ID: 22048728
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG
Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641
[TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
18. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
20. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):258-61. PubMed ID: 20224542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
